Status:

ACTIVE_NOT_RECRUITING

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

Lead Sponsor:

St. Jude Children's Research Hospital

Conditions:

Hodgkin Lymphoma

Eligibility:

All Genders

Up to 21 years

Phase:

PHASE2

Brief Summary

This phase II trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with favorable-risk Hodgkin lymphoma. Drugs used in chemotherapy, s...

Detailed Description

Patients receive doxorubicin hydrochloride intravenously (IV) and vinblastine IV on day 1 of weeks 1, 3, 5, and 7; mechlorethamine hydrochloride IV on day 1 of weeks 1 and 5; vincristine sulfate IV an...

Eligibility Criteria

Inclusion

  • Histologically confirmed, previously untreated Hodgkin lymphoma.
  • Age: Participants must be 21 years of age or younger
  • Stage must be classified as one of the following:
  • Ann Arbor stage IA or IIA with:
  • Non-bulky mediastinal disease (\< 33% mediastinal to thoracic ratio on CXR)
  • \< 3 nodal regions involved on the same side of the diaphragm
  • No "E" lesion
  • Female patients who are post-menarchal must have a negative pregnancy test. Patients of reproductive potential must agree to use an effective contraceptive method.
  • Signed informed consent
  • If re-evaluation of a patient's disease shows intermediate risk features, the patient will be removed from the HOD08.

Exclusion

  • Intermediate or High risk disease, defined as Stage IB, any III or IV or IA/IIA with "E" lesion(s), 3 or more nodal sites involved, or bulky mediastinal adenopathy

Key Trial Info

Start Date :

June 5 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2028

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT00846742

Start Date

June 5 2009

End Date

October 1 2028

Last Update

December 8 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Packard Children's Hospital, Stanford University

Palo Alto, California, United States, 94304

2

Rady Children's Hospital- San Diego

San Diego, California, United States, 92123

3

Children's Hospital of Illinois at OSF St. Francis Medical Center

Peoria, Illinois, United States, 61637

4

Maine Children's Cancer Program (MCCP)

Scarborough, Maine, United States, 04074

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma | DecenTrialz